Blog

The National Health Surveillance Agency (ANVISA) has established clear guidelines for the compassionate use of medical devices through Resolution RDC...

Xavier Bazin was at Père-Lachaise to pay a final tribute to Professor Luc Montagnier. In recent years, I have had the...

With the advancement of digital technology, Software as Medical Devices (SaMD) has become an essential part of healthcare innovation. These...

The commercialization of medical devices (MD) in Brazil is regulated by ANVISA (National Health Surveillance Agency), which requires different levels...

Resolution No. 902, dated September 6, 2024, published by ANVISA, establishes that products subject to health surveillance that undergo changes...

The National Institute for Quality Control in Health (INCQS) plays a key role in ensuring that health-related products, including medical...

The importation of medical device samples is a process that involves several stages and regulatory requirements. This process can be...

The Collegiate Board of the Brazilian Health Regulatory Agency (ANVISA) has announced an important update to the rules for the...

Published in December 2019, RDC 327/2019 sets out the procedures for granting Sanitary Authorization for the manufacturing and importation of...